BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 27711077)

  • 1. RelB/NF-κB links cell cycle transition and apoptosis to endometrioid adenocarcinoma tumorigenesis.
    Ge QL; Liu SH; Ai ZH; Tao MF; Ma L; Wen SY; Dai M; Liu F; Liu HS; Jiang RZ; Xue ZW; Jiang YH; Sun XH; Hu YM; Zhao YX; Chen X; Tao Y; Zhu XL; Ding WJ; Yang BQ; Liu DD; Zhang XR; Teng YC
    Cell Death Dis; 2016 Oct; 7(10):e2402. PubMed ID: 27711077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RelB sustains endocrine resistant malignancy: an insight of noncanonical NF-κB pathway into breast Cancer progression.
    Wang M; Zhang Y; Xu Z; Qian P; Sun W; Wang X; Jian Z; Xia T; Xu Y; Tang J
    Cell Commun Signal; 2020 Aug; 18(1):128. PubMed ID: 32807176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative NF-κB signaling promotes colorectal tumorigenesis through transcriptionally upregulating Bcl-3.
    Tao Y; Liu Z; Hou Y; Wang S; Liu S; Jiang Y; Tan D; Ge Q; Li C; Hu Y; Liu Z; Chen X; Wang Q; Wang M; Zhang X
    Oncogene; 2018 Nov; 37(44):5887-5900. PubMed ID: 29973688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RelB/p52 NF-kappaB complexes rescue an early delay in mammary gland development in transgenic mice with targeted superrepressor IkappaB-alpha expression and promote carcinogenesis of the mammary gland.
    Demicco EG; Kavanagh KT; Romieu-Mourez R; Wang X; Shin SR; Landesman-Bollag E; Seldin DC; Sonenshein GE
    Mol Cell Biol; 2005 Nov; 25(22):10136-47. PubMed ID: 16260626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive Evaluation of Nuclear Factor-κΒ Expression Patterns in Non-Small Cell Lung Cancer.
    Giopanou I; Lilis I; Papaleonidopoulos V; Marazioti A; Spella M; Vreka M; Papadaki H; Stathopoulos GT
    PLoS One; 2015; 10(7):e0132527. PubMed ID: 26147201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) promotes glioma cell invasion through induction of NF-κB-inducing kinase (NIK) and noncanonical NF-κB signaling.
    Cherry EM; Lee DW; Jung JU; Sitcheran R
    Mol Cancer; 2015 Jan; 14(1):9. PubMed ID: 25622756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rac1, but not Rac1B, stimulates RelB-mediated gene transcription in colorectal cancer cells.
    Matos P; Jordan P
    J Biol Chem; 2006 May; 281(19):13724-13732. PubMed ID: 16551621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [NF-κB subunits regulate maspin expression in prostate cancer cells in vitro].
    Ma L; Shen YY; Zhou P; Zhou J; Guo F
    Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):165-8. PubMed ID: 22780967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maspin expression is regulated by the non-canonical NF-κB subunit in androgen-insensitive prostate cancer cell lines.
    Guo F; Kang S; Zhou P; Guo L; Ma L; Hou J
    Mol Immunol; 2011 Oct; 49(1-2):8-17. PubMed ID: 21856005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RelA repression of RelB activity induces selective gene activation downstream of TNF receptors.
    Jacque E; Tchenio T; Piton G; Romeo PH; Baud V
    Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14635-40. PubMed ID: 16192349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malt1-dependent RelB cleavage promotes canonical NF-kappaB activation in lymphocytes and lymphoma cell lines.
    Hailfinger S; Nogai H; Pelzer C; Jaworski M; Cabalzar K; Charton JE; Guzzardi M; Décaillet C; Grau M; Dörken B; Lenz P; Lenz G; Thome M
    Proc Natl Acad Sci U S A; 2011 Aug; 108(35):14596-601. PubMed ID: 21873235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RelB, together with RelA, sustains cell survival and confers proteasome inhibitor sensitivity of chronic lymphocytic leukemia cells from bone marrow.
    Xu J; Zhou P; Wang W; Sun A; Guo F
    J Mol Med (Berl); 2014 Jan; 92(1):77-92. PubMed ID: 24042463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The NF-κB RelB protein is an oncogenic driver of mesenchymal glioma.
    Lee DW; Ramakrishnan D; Valenta J; Parney IF; Bayless KJ; Sitcheran R
    PLoS One; 2013; 8(2):e57489. PubMed ID: 23451236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A roadmap of constitutive NF-κB activity in Hodgkin lymphoma: Dominant roles of p50 and p52 revealed by genome-wide analyses.
    de Oliveira KA; Kaergel E; Heinig M; Fontaine JF; Patone G; Muro EM; Mathas S; Hummel M; Andrade-Navarro MA; Hübner N; Scheidereit C
    Genome Med; 2016 Mar; 8(1):28. PubMed ID: 26988706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Function of alternative NF-κB activity in B-cell chronic lymphocytic leukemia cells].
    Xu J; Zhou P; Guo F
    Zhonghua Xue Ye Xue Za Zhi; 2014 Jan; 35(1):40-5. PubMed ID: 24602731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations of p53 and KRAS activate NF-κB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells.
    Yang L; Zhou Y; Li Y; Zhou J; Wu Y; Cui Y; Yang G; Hong Y
    Cancer Lett; 2015 Feb; 357(2):520-6. PubMed ID: 25499080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NF-κB pathways in hematological malignancies.
    Gasparini C; Celeghini C; Monasta L; Zauli G
    Cell Mol Life Sci; 2014 Jun; 71(11):2083-102. PubMed ID: 24419302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NF-κB Participates in the Stem Cell Phenotype of Ovarian Cancer Cells.
    Gonzalez-Torres C; Gaytan-Cervantes J; Vazquez-Santillan K; Mandujano-Tinoco EA; Ceballos-Cancino G; Garcia-Venzor A; Zampedri C; Sanchez-Maldonado P; Mojica-Espinosa R; Jimenez-Hernandez LE; Maldonado V
    Arch Med Res; 2017 May; 48(4):343-351. PubMed ID: 28886875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression and activation of NF-kappaB family proteins during oral carcinogenesis: Role of high risk human papillomavirus infection.
    Mishra A; Bharti AC; Varghese P; Saluja D; Das BC
    Int J Cancer; 2006 Dec; 119(12):2840-50. PubMed ID: 16998793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-503 suppresses proliferation and cell-cycle progression of endometrioid endometrial cancer by negatively regulating cyclin D1.
    Xu YY; Wu HJ; Ma HD; Xu LP; Huo Y; Yin LR
    FEBS J; 2013 Aug; 280(16):3768-79. PubMed ID: 23731275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.